This test may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for COVID-19... Dec 03
Alembic has a cumulative total of 137 ANDA approvals (118 final approvals and 19 tentative approvals) from USFDA... Dec 03
Gavreto is a once-daily, oral precision therapy designed to selectively target RET alterations, including fusions and mutations... Dec 03
-Advertisements-